expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology Today
qolumnistRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)TRT WorldVečer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidAgenciesReutersLuke TressLazar BermanShira SilkoffPeter BaumJessica SteinbergZev StubStav LevatonJeremy SharonNurit Yohanan
Gideon LevyNava FreibergThe Asahi ShimbunThe Japan News EditorialGrace Gilson
Tarik Cyril AmarSam SokolAriela KarmelSonjib Chandra DasDiana BletterRossella Tercatin
Stefano LusaAmira HassAhmad IbsaisAsaf Elia-ShalevJackie HajdenbergSam Goldstein Ph.d
Mort LaitnerAndrew Lapin
Robert SarnerQi Wang Ph.dNoam LehmannTatjana PihlarPisma BralcevOdeh BisharatYagil LevyAmanda Borschel-Dan
Mark Travers Ph.dE-International Relations
Andrew Silow-Carroll
Ellen Ginsberg SimonBruce Y. Lee M.dSteve StrifflerCharlie SummersPhilissa CramerAdnan Hmidan
|
 |
Some popular weight loss drugs may lower the risk of dementia and stroke for patients with Type 2 diabetes and obesity, new research published in JAMA Network suggests.
Patients taking © The Hill
visit website 
login
who are we?
contact us
qosheapp
